Skip to main content
SpringerLink
Log in

Karyotypic progression in human tumors

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Karyotypic progression may be viewed in at least two ways. One approach seeks evidence for increasing and progressive deviation from the normal chromosome pattern in tumors. The clearest examples, found in some leukemias, are those in which successive karyotypic changes are superimposed on an already aberrant cell population. Evidence of chromosomal progression within solid tumors is far less frequent, possibly because the tumors themselves are at a relatively late stage in their evolution. An alternative approach, therefore, attempts to correlate the extent of karyotypic deviation with other aspects of tumor progression. Recent data, based on classical cytogenetic analyses and flow cytometry, are presented to determine relationships between karyotype and specific origin and morphology of tumors. The predominant theme which emerges, not surprisingly, is that the more deviant chromosome patterns are associated with other measures of increased biologic malignancy. What is surprising is the degree to which these properties are expressed in primary tumors and the relative lack of evidence for further karyotypic evolution with recurrence or metastasis.

Examples of genetic instability, evolution through polyploidy, gene amplification, and selection for specific chromosomal rearrangement are found in populations of premalignant and malignant human cells. There is increasing recognition of the importance of tumor-specific chromosome aberrations in the stepwise progression from the normal to the fully neoplastic cell.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Foulds L: The experimental study of tumor progression: a review. Cancer Res (14): 327–339, 1954.

    Google Scholar 

  2. Dexter DL, Kowalski HM, Blazer BA, Fligiel Z, Vogel R, Heppner GH: Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res (38): 3174–3181, 1978.

    Google Scholar 

  3. Heppner GH, Dexter DL, DeNucci T, Miller FR, Calabresi P: Heterogeneity and drug sensitivity among tumor cell subpopulations of a single mammary tumor. Cancer Res (38): 3758–3763, 1978.

    Google Scholar 

  4. Yunis JJ, Ramsay N: Retinoblastoma and subband deletion of chromosome 13. Am J Dis Child (132): 161–163, 1978.

    Google Scholar 

  5. Fowler HW: A dictionary of modern english usage. Oxford University Press, London, 1954.

    Google Scholar 

  6. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science (132): 1497, 1960.

    Google Scholar 

  7. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by Quinacrin fluorecence and Giemsa staining. Nature (243): 290–293, 1973.

    Google Scholar 

  8. Yunis JJ: Chromosomal defects in cancer. In: Schimke RT (ed), Gene amplification. Cold Spring Harbor Laboratory, New York, 1982, pp 297–305.

    Google Scholar 

  9. Sonta SI, Sandberg AA: Chromosomes and causation of human cancer and leukemia XXIV unusual and complex PH1—translocations and their clinical significance. Blood (50): 691–697, 1977.

    Google Scholar 

  10. Rowley JD: Chromosome abnormalities in cancer. Cancer Genet Cytogenet (2): 175–198, 1980.

    Google Scholar 

  11. Gebhart E: Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing. Human Genet (58): 235–254, 1981.

    Google Scholar 

  12. Vainio H, Sorsa M: Chromosome aberrations and their relevance to metal carcinogenesis. Environ Health Perspect (40): 173–180, 1981.

    Google Scholar 

  13. Yunis JJ, Bloomfield CD, Ensrud K: All patients with acute nonlymphocytic leukemia may have a chromosomal defect. N Engl. J Med (305): 135–139, 1981.

    Google Scholar 

  14. Wake N, Slocum HK, Rustum YM, Matsui S, Sandberg AA: Chromosomes and causation of human cancer and leukemia. XLIV. A method for chromosome analysis of solid tumors. Cancer Genet Cytogenet (3): 1–10, 1981.

    Google Scholar 

  15. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science (197): 461–463, 1977.

    Google Scholar 

  16. Nowell PC. Cytogenetics: In: Becker FF (ed), Cancer—a comprehensive treatise, vol I, 2nd Ed. Plenum Press, New York, 1982, pp 3–46.

    Google Scholar 

  17. Golumb HM, Rowley JD: Significance of cytogenetic abnormalities in acute leukemias. Human Pathol (12): 515–522, 1981.

    Google Scholar 

  18. Ponder BAJ: Genetics and cancer. Biochim Biophys Acta (605): 369–410, 1980.

    Google Scholar 

  19. Sandberg AA. Chromosomes in human cancer and leukemia. Elsevier/North Holland, New York, 1980.

    Google Scholar 

  20. Arlett CF, Lehmann AR. Human disorders showing increased sensitivity to the induction of genetic damage. Ann Rev Genet (12): 95–115, 1978.

    Google Scholar 

  21. Harnden DG: Mechanisms of genetic susceptibility to cancer. In: Pullman B, Tso PO, Gelboin H (eds), Carcinogenesis: fundamental mechanisms and environmental effects. Reidel, Dordrecht, 1980, pp 235–244.

    Google Scholar 

  22. Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA: Ataxia telangiectasia: a human mutant with abnormal radiation sensitivity. Nature (258): 427–429, 1975.

    Google Scholar 

  23. Cox R, Hosking GP, Wilson J: Ataxia-telangiectasia evaluation of radio sensitivity in cultured skin fibroblasts as a diagnostic test. Arch Dis Child (53): 386–390, 1978.

    Google Scholar 

  24. Auerbach AD, Wolman SR: Susceptibility of Fanconi's anemia fibroblasts to chromosome damage by carcinogens. Nature (261): 494–496, 1976.

    Google Scholar 

  25. Auerbach AD, Wolman SR. Carcinogen-induced chromosome breakage in chromosome instability syndromes. Cancer Genet Cytogenet (1): 21–28, 1979.

    Google Scholar 

  26. Levitt R, Pierre RV, White WO, Siekert RG: Atypical lymphoid leukemia in ataxia telangiectasia. Blood (52): 1003–1011, 1978.

    Google Scholar 

  27. McCaw BK, Hecht F, Harnden DG, Teplitz RL: Somatic rearrangement of chromosome 14 in human lymphocytes. Proc Natl Acad Sci USA (72): 2071–2075, 1975.

    Google Scholar 

  28. Saxon A, Stevens RH, Golde DW: Helper and suppressor T-lymphocyte leukemia in ataxia telangiectasia. N Eng J Med (300): 700–704, 1979.

    Google Scholar 

  29. Al-Saadi AA, Palutke M, Dumar GK: Evolution of chromosomal abnormalities in sequential cytogenetic studies of ataxia telangiectasia. Human Genet (55): 23–29, 1980.

    Google Scholar 

  30. Gardner EJ, Rogers SW, Woodward S: Numerical and structural chromosome aberrations in cultured lymphocytes and cutaneous fibroblasts of patients with multiple adenomas of colorectum. Cancer (49): 1413–1419, 1982.

    Google Scholar 

  31. Hsu TC, Pathak S, Samaan N, Hickey CR: Chromosome instability in patients with medullary carcinoma of the thyroid. J Am Med Assoc (246): 2046–2048, 1981.

    Google Scholar 

  32. Danes BS: Occurence of in vitro tetraploidy in the heritable colon cancer syndromes. Cancer (48): 1596–1598, 1981.

    Google Scholar 

  33. Rowley JD: Down syndrome and acure leukaemia: increased risk may be due to trisomy 21. Lancet (ii): 1020–1022, 1981.

    Google Scholar 

  34. Kaneko Y, Rowley JD, Variakojis D, Chilcote RR, Moohr JW, Patel D: Chromosome abnormalities in Down's syndrome patients with acute leukemia. Blood (58): 459–466, 1981.

    Google Scholar 

  35. Heaton DS, Fitzgerald PH, Fraser GJ, Abbott GD: Transient leukemoid proliferation of the cytogenetically unbalanced +21 cell line of a constitutional mosaic boy. Blood (57): 883–887, 1981.

    Google Scholar 

  36. Lazarus KH, Heerema NA, Palmer CG, Baehner RL: The myeloproliferative reaction in a child with Down syndrome: cytological and chromosomal evidence for a transient leukemia. Am J Hematol (11): 417–423, 1981.

    Google Scholar 

  37. Braun DL, Green MD, David R, Wolman SR, Rauson A, Muggia FM: Testicular cancer and Down's syndrome: a possible association (submitted for publication).

  38. Scully RE: Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Pediatr Adolesc Endocr (8): 203–217, 1981.

    Google Scholar 

  39. Geraedts JPM, Mol A, Briet E, Hartgrink-Groeneveld CA, den Ottolander GJ: Klinefelter syndrome: predisposition to acute nonlymphocytic leukemia?. Lancet (i): 774, 1980.

    Google Scholar 

  40. Muts-Homsma SJ, Muller MP, Geraedts JP: Klinefelter's syndrome and acute non-lymphocytic leukemia. Blut (44): 15–20, 1982.

    Google Scholar 

  41. Sogge MR, McDonald SD and Cofold PB: The malignant potential of the dysgenetic germ cell in Klinefelter's syndrome. Am J Med (66): 515–518, 1979.

    Google Scholar 

  42. Vogel F, Motulsky AG: Human genetics, problems and approaches. Springer-Verlag, New York, 1979.

    Google Scholar 

  43. DeGreff I, Geraedts JPM, Leeksma CHW: Malignant hematologic disorders in two Robertsonian 13;14 translocation carriers. Cancer Genet Cytogenet (7): 181–184, 1982.

    Google Scholar 

  44. Nora A, Heideman R, Peakman D, Morse H: Cytogenetic studies in an acute leukemia patient following cerebellar astrocytoma. Human Genet (50): 157–161, 1979.

    Google Scholar 

  45. Sanchez M, Bahng K, Ibrahim I: Papillary renal cell carcinoma in two brothers associated with translocation of chromosomes 13 and 14. (Abstract) 71st Annual Meeting Int Acad Pathol, Boston, Mass, 1982.

  46. Atkin NB, Brito-Babapulle V: Heterochromatin polymorphism and human cancer. Cancer Genet Cytogenet (3): 261–272, 1981.

    Google Scholar 

  47. Riccardi VM, Sujansky E, Smith AC, Francke U: Chromosomal imbalance in the aniridia-Wilm's tumor association: 11p interstitial deletion. Pediatrics (61): 604–610, 1978.

    Google Scholar 

  48. Balaban G, Gilbert F, Nichols WW, Meadows AT, Shields J: Abnormalities of chromosome #13 in retinoblastomas from individuals with normal constitutional karyotypes. Cancer Genet Cytogenet (6): 213–221, 1982.

    Google Scholar 

  49. Gardner HA, Gallie BL, Knight LA, Phillips RA: Multiple karyotypic changes in retinoblastoma tumor cells: presence of normal chromosome No. 13 in most tumors. Cancer Genet Cytogenet (6): 201–211, 1982.

    Google Scholar 

  50. Strong LC, Riccardi VM, Ferrell RE, Sparkes RS: Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science (213): 1501–1503, 1981.

    Google Scholar 

  51. Khush GS: Cytogenetics of aneuploids. Academic Press, New York, London, 1973, p 260.

    Google Scholar 

  52. Sybenga J: General cytogenetics. Elsevier, New York, 1972, p 251.

    Google Scholar 

  53. Ber R, Weiner F, Fenyo EM: Proof of in vivo fusion of murine tumor cells with host cells by universal fusers. J Natl Cancer Inst (60): 931–933, 1978.

    Google Scholar 

  54. Kerbel RS, Lagarde AE, Dennis JW, Donaghue TP: Spontaneous host cell X tumor cell hybridization in vivo: contribution to the emergence of metastatic cell variants. Mol Cell Biol (in press).

  55. Barrett CJ, Crawford BD, Tso PO: The role of somatic mutation in multistage model of carcinogenesis. In: Mishra N, Dunkel VC, Mehlman M (eds), Mammalian cell transformation by chemical carcinogens. Senate Press, New Jersey, 1980, pp 467–501.

    Google Scholar 

  56. Danes BS, Bulow S, Svendsen LB: Hereditary colon cancer syndromes: an in vitro study. Clin Genet (18): 128–136, 1980.

    Google Scholar 

  57. Delhanty JDA, Pritchard MB, Bussey JHR, Morson BC: Tetraploid fibroblasts and familial polyposis coli. Lancet (i): 1365, 1980.

    Google Scholar 

  58. Delhanty JDA, Davis MB, Wood J: Chromosome instability in lymphocytes, fibroblasts and colon epitheliallike cells from patients with familial polyposis coli. Mammalian Chromosome Newsletter (23): 69–80, 1982.

    Google Scholar 

  59. Harris H: The city of Berlin and some modern approaches to the cancer problem. In: Schweiger HG (ed), International Cell biology 1980–1981. Springer-Verlag, Berlin, 1981, pp 3–12.

    Google Scholar 

  60. Pollack R, Wolman SR, Vogel A: Reversion of virustransformed cell lines: hyperploidy accompanies retention of viral genes. Nature (228): 938, 967–970, 1970.

    Google Scholar 

  61. Atkin NB, Kay R: Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br J Cancer (40): 210–221, 1979.

    Google Scholar 

  62. Barlogie B, Johnston DA, Smallwood L, Raber MN, Maddox AM, Latreille J, Swartzendruber DE, Drewinko B: Prognostic implications of ploidy and proliferative activity in human solid tumors. Cancer Genet Cytogenet (6): 17–28, 1982.

    Google Scholar 

  63. Levan G, Mitelman F: The different origin of primary and secondary chromsome aberrations in cancer. Haematol Blood Trans (26): 160–166, 1981.

    Google Scholar 

  64. Nowell PC: Cytogenetics of preleukemia. Cancer Genet Cytogenet (5): 265–278, 1982.

    Google Scholar 

  65. Rowley JD: General report on the second international workshop on chromosomes in leukemia. Int J Cancer (26): 531–533, 1980.

    Google Scholar 

  66. Testa JR, Kanofsky JR, Rowley JDl Baron JM, Vardiman JW: Karyotypic patterns and their clinical significance in polycythemia vera. Am J Hematol (11): 29–45, 1981.

    Google Scholar 

  67. Sieff CA, Chessells JM, Harvey BAM, Pickthall VJ, Lawler SD: Monosomy 7 in childhood: a myeloproliferative disorder. Br J Haematol (49): 235–249, 1981.

    Google Scholar 

  68. Gahrton G, Friberg K, Zech L, Lindsten J: Duplication of part of chromosome No. 1 in myeloproliferative diseases. Lancet (i): 96–97, 1978.

    Google Scholar 

  69. Swolin B, Weinfeld A, Ridell B, Waldenstrom J, Westin J, On the 5q- deletion: clinical and cytogenetic observations in ten patients and review of the literature. Blood (58): 986–993, 1981.

    Google Scholar 

  70. Borgstrom GH, Vuopio P, de la Chapelle A: Abnormalities of chromosome No. 17 in myeloproliferative disorders. Cancer Genet Cytogenet (5): 123–135, 1982.

    Google Scholar 

  71. Rowley JD: Nonrandom gain of particular chromosomes in human malignant hematologic disease. In: Schimke RT (ed), Gene amplification. Cold Spring Harbor Laboratory, New York, 1982, pp 291–296.

    Google Scholar 

  72. Fleischman EW, Prigogina EL, Volkova MA, Frenkel MA, Zakhartchenko NA, Konstantinova LN, Puchkova GP, Balakirev SA: Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia. Hum Genet (58): 285–293, 1981.

    Google Scholar 

  73. Rowley J. Golomb H, Dougherty C: 15/17 translocation: consistent abnormality in acute promyelocytic leukemia. Lancet (i): 549, 1977.

    Google Scholar 

  74. Sakurai M, Sandberg AA: Chromosomes and causation of human cancer and leukemia IX prognostic and therapeutic value of chromosomal findings in acute myeloblastic leukemia. Cancer (33): 1548–1557, 1974.

    Google Scholar 

  75. Hagemeijer A, Hahlen K, Abels J: Cytogenetic followup of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia. Cancer Genet Cytogenet (3): 109–124, 1981.

    Google Scholar 

  76. Kamada N, Dohy H, Okada K, Oguma N, Kuramoto A, Tanaka K, Uchino H: In vivo and in vitro activity of neutrophil alkaline phosphatase in acute myelocytic leukemia with 8;21 translocation. Blood (58): 1213–1217, 1981.

    Google Scholar 

  77. Shiraishi Y, Taguchi H, Niiya K, Shiomi F, Kikukawa K, Kubonishi S, Ohmura T, Hamawaki M, Ueda N: Diagnostic and prognostic significance of chromosome abnormalities in marrow and mitogen response of lymphocytes of acute nonlymphocytic leukemia. Cancer Genet Cytogenet (5): 1–24, 1982.

    Google Scholar 

  78. Third International Workshop on Chromosomes in Leukemia, 1980: Chromosomal abnormalities in acute lymphoblastic leukemia: structural and numerical changes in 234 cases. Cancer Genet Cytogenet (4): 101–110, 1981.

  79. Bloomfield CD, Lindquist LL, Arthur D, McKenna RW, Le Bien TW, Peterson BA, Nesbit ME: Chromosomal abnormalities in acute lymphoblastic leukemia. Cancer Res (41): 4838–4843, 1981.

    Google Scholar 

  80. Brodeur GM, Williams DL, Look AT, Bowman WP, Kalwinsky DK: Near-haploid acute lymphoblastic leukemia: A unique subgroup with a poor prognosis? Blood (58): 14–19, 1981.

    Google Scholar 

  81. Klein G: The role of viral transformation and cytogenetic changes in viral oncogenesis. Ciba Found Symp (66): 335–348, 1979.

    Google Scholar 

  82. Berger R, Bernheim A, Sigaux F, Daniel MT, Valensi F, Flandrin G: Acute monocytic leukemia chromosome studies. Leuk Res (6): 17–26, 1982.

    Google Scholar 

  83. Ueschima Y, Fukuhara S, Hattori T, Uchiyama T, Takatsuki K, Uchino H: Chromosome studies in adult T-cell leukemia in Japan: significance of trisomy 7. Blood (58): 420–425, 1981.

    Google Scholar 

  84. Gahrton G, Robert KH: Chromosomal aberrations in chronic B-cell lymphocytic leukemia. Cancer Genet Cytogenet (6): 171–181, 1982.

    Google Scholar 

  85. Nowell PC, Finan JB, Vonderheid EC: Clonal characteristics of cutaneous T-cell lymphomas: cytogenetic evidence from blood, lymph nodes, and skin. J Invest Dermatol (78): 69–75, 1982.

    Google Scholar 

  86. Whang-Peng J, Bunn PA, Knutsen T, Matthews MJ, Schechter G, Minna JD: Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer (50): 1539–1553, 1982.

    Google Scholar 

  87. Barlogie B, Latreille J, Freireich EJ, Fu CT, Mellard D, Meistrich M, Andreeff M: Characterization of hematologic malignancies by flow cytometry. Blood Cells (6): 719–744, 1980.

    Google Scholar 

  88. Pedersen-Bjergaard J, Larsen SO: Incidence of acute nonlymphocyic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's Disease. N Engl J Med (307): 965–971, 1982.

    Google Scholar 

  89. Anderson RL, Bagby GC, Richert-Boe K, Magenis RE, Koler RD: Therapy-related preleukemic syndrome. Cancer (47): 1867–1871, 1981.

    Google Scholar 

  90. Zankl H, Zang KD: Correlations between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet (1): 351–356, 1980.

    Google Scholar 

  91. Zang KD: Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet (6): 249–274, 1982.

    Google Scholar 

  92. Shapiro JR, Yung WKA, Shapiro WR: Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res (41): 2349–2359, 1981.

    Google Scholar 

  93. Mork SJ, Laerum OD: DNA Distribution in human gliomas in vivo and in vitro. Flow Cytometry (IV): 403–406, 1980.

    Google Scholar 

  94. Frederiksen P, Bichel P: Sequential flow cytometric analysis of the single cell DNA content in recurrent human brain tumours. Flow Cytometry (IV): 398–401, 1980.

    Google Scholar 

  95. gilbert F, Balaban G, Moorhead P, Bianchi D, Schlesinger H: Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet (7): 33–42, 1982.

    Google Scholar 

  96. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA: Cytogenetic features of human neuroblastomas and cell lines. Cancer Res (41): 4678–4686, 1981.

    Google Scholar 

  97. Kanzaki T, Eto H, Umezawa A, Maeda T, Iwase H, Ito M: Morphological, biological, and biochemical characteristics of a benign human trichilemmoma cell line in vivo and in vitro. Cancer Res (41): 2468–2475, 1981.

    Google Scholar 

  98. Wolman SR, Steinberg ML, Defendi V: Simian Virus 40-induced chromosome change in human epidermal cultures. Cancer Genet Cytogenet (2): 39–46, 1980.

    Google Scholar 

  99. Frentz G, Moller U: DNA measurements by single nuclei flow cytometry in human actinic skin lesions. J Invest Dermatol (77): 431–433, 1981.

    Google Scholar 

  100. Mark J, Dahlenfors R, Ekedahl C, Stenman G: The mixed salivary gland tumor-A normally benign human neoplasm frequently showing specific chromosomal abnormalities. Cancer Genet Cytogenet (2): 231–241, 1980.

    Google Scholar 

  101. Kovacs G: Preferential involvement of chromosome 1q in a primary breast carcinoma. Cancer Genet Cytogenet (3): 125–129, 1981.

    Google Scholar 

  102. Satva-Prakash KL, Pathak S, Hsu TC, Olive M, Calleau R: Cytogenetic analysis on eight human breast tumor cell lines: high frequencies of 1q-, 11q and HeLa-like marker chromosomes. Cancer Genet Cytogenet (3): 61–73, 1981.

    Google Scholar 

  103. Smith HS, Lan S, Ceriani R, Hackett AJ, Stampfer MR: Clonal proliferation of cultured nonmalignant human breast epithelia. Cancer Res (41): 4637–4643, 1981.

    Google Scholar 

  104. Smith HS, Wolman SR, Lippman M, Hackett AJ: Human breast cancer metastases: culture, characterization and sensitivity to adriamycin. Proc. Am Assoc Cancer Res (Abstract 118) (24): 30, 1983.

    Google Scholar 

  105. Olszewski W, Darzynkiewicz Z, Rosen PP, Schwartz MK, Melamed MR: Flow cytometry of breast carcinoma: 1. Relation of DNA ploidy level to histology and estrogen receptor. Cancer (48): 980–984, 1981.

    Google Scholar 

  106. Auer GU, Caspersson TO, Gustafsson SA, Humla SA, Ljung MB, Nordenskjold BA, Silfversward D, Wallgren AS: Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas. Anal Quant Cytol (2): 280–284, 1980.

    Google Scholar 

  107. Whang-Peng J, Bunn PA, Kao-Shan CS, Lee EC, Carney DN, Gazdar A, Minna JD: A nonrandom chromosomal abnormality, del 3p (14–23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet (6): 119–134, 1982.

    Google Scholar 

  108. Wurster-Hill DH, Maurer LH: Cytogenetic diagnosis of cancer: abnormalities of chromosomes and polyploid levels in the bone marrow of patients with small cell anaplastic carcinoma of the lung. J Natl Cancer Inst (61): 1065–1075, 1978.

    Google Scholar 

  109. Wurster-Hill DH: personal communication.

  110. Falor WH, Ward RM, Brezler MR: Diagnosis of pleural effusions by chromosome analysis. Chest (81): 193–197, 1982.

    Google Scholar 

  111. Blondal T, Bengtsson A: Nuclear DNA measurements in squamous cell carcinoma of the lung: a guide for prognostic evaluation. Anti-cancer Res (1): 79–86, 1981.

    Google Scholar 

  112. Reichmann A, Martin P, Levin B: Karyotypic findings in a colonic villous adenoma. Cancer Genet Cytogenet (7): 51–57, 1982.

    Google Scholar 

  113. Reichmann A, Martin P, Levin B: Chromosomal banding patterns in human large bowel cancer. Int J Cancer (28): 431–440, 1981.

    Google Scholar 

  114. Reichmann A, Levin B: personal communication.

  115. Reichmann A, Levin B, Martin P: Human large bowel cancer: correlation of clinical and histopathological features with banded chromosomes. Int J Cancer (29): 625–630, 1982.

    Google Scholar 

  116. Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A: DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Nat Cancer Inst (6): 15–22, 1982.

    Google Scholar 

  117. Petrova AS, Subrichina GN, Tschistjakova OV, Lukina TA, Weiss H, Wildner G: Flow cytofluorimetry, cytomorphology and histology in gastric carcinoma. Oncology (37): 318–324, 1980.

    Google Scholar 

  118. Cohen AJ, Li FP, Berg S, Marchetro DJ, Tsai S, Jacobs SC, Brown RS: Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (301): 592–595, 1979.

    Google Scholar 

  119. Hagemeijer A, Hoehn W, Smit EME: Cytogenetic analysis of human renal carcinoma cell lines of common origin (NC 65). Cancer Res (39): 4662–4667, 1979.

    Google Scholar 

  120. Pathak S, Strong LC, Ferrell RE, Trindade A: Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. Science (217): 939–941, 1982.

    Google Scholar 

  121. Summers JL, Falor WH, Ward R: A 10-year analysis of chromosomes in non-invasive papillary carcinoma of the bladder. J Urol (125): 177–178, 1981.

    Google Scholar 

  122. Javadpour N, Roy JB, Bottomley R, Dagg K: Combined cell surface antigens and chromosomal studies in bladder cander. Urology (19): 29–32, 1982.

    Google Scholar 

  123. Jakobsen A, Bichel P, Sell A: Flow cytometric investigations of human bladder carcinoma compared to histological classification. Urol Res (7): 109–112, 1979.

    Google Scholar 

  124. Gustafson H, Tribukait B, Esposti PL: DNA profile and tumour progression in patients with superfical bladder tumours. Urol Res (10): 13–18, 1982.

    Google Scholar 

  125. Klein FA, Melamed MR, Whitmore WF, Herr HW, Sogani PC, Darzynkiewicz Z: Characterization of bladder papilloma by two-parameter DNA-RNA flow cytometry. Cancer Res (42): 1094–1097, 1982.

    Google Scholar 

  126. Wake N, Hreshchyshyn MM, Piver SM, Matsui S-I, Sandberg AA: Specific chromosome change in ovarian cancer. Cancer Genet Cytogenet (2): 87–88, 1980.

    Google Scholar 

  127. Trent JM: Chromosomal alterations in clonogenic human tumor cells resistant to cytostatic agents. In: Schimke RT (ed), Gene amplification. Cold Spring Harbor Laboratory, New York, 1982, pp 99–106.

    Google Scholar 

  128. Trent JM: Cytogenetic analysis of human tumor cells cloned in agar. In: Salmon SE (ed), Cloning of human stem cells. New York, 1980, pp 165–177.

  129. Whang-Peng J, Knutsen T, Douglass EC, Chu E, Young RC: Is 6q-a specific chromosomal marker for ovarian cancer? (Abstract#123) Proc Am Assoc Cancer Res, 1982, p 34.

  130. Kusyk J, Seski JC, Medlin V, Edwards CL: Progressive chromosome changes associated with different sites of one ovarian carcinoma. J Natl Cancer Inst (66): 1021–1025, 1981.

    Google Scholar 

  131. Atkin NB, Pickthall VJ: Chromosomes 1 in 14 ovarian cancers, Heterochromatin variants and structural changes. Human Genet (38): 25–33, 1977.

    Google Scholar 

  132. Wang N, Trend B, Bronson DL, Fraley EE: Nonrandom abnormalities in chromosomes 1 in human testicular cancers. Cancer Res (40): 796–802, 1980.

    Google Scholar 

  133. Cotte C, Raghavan D, McIlhinney RAJ, Monaghan P: Characterization of a new human cell line derived from a xenografted embryonal carcinoma. In Vitro (18): 739–749, 1982.

    Google Scholar 

  134. Zimmermann A, Truss F: The prognostic power of flow-through cytophotometric DNA determinations for testicular diseases. Anal quant Cytol (2): 247–251, 1980.

    Google Scholar 

  135. Kreicbergs A, Zetterberg A, Soderberg G: The prognostic significance of nuclear DNA content in chondrosarcoma. Anal Quant Cytol (2): 272–279, 1980.

    Google Scholar 

  136. Brodeur GM, Tsiatis AA, Williams DL, Luthardt FW, Green AA: Statistical analysis of cytogenetic abnormalities in human cancer cells. Cancer Genet Cytogenet (7): 137–152, 1982.

    Google Scholar 

  137. Rigby PWJ: The oncogenic circle closes. Nature (297): 451–453, 1982.

    Google Scholar 

  138. Blair DG, Cooper CS, Oskarsson MK, Eader LA, Vande Woude GF: New method for detecting cellular transforming genes. Science (218): 1122–1125, 1982.

    Google Scholar 

  139. Smith BL, Anisowicz A, Chadosh LA, Sager R: DNA transfer of focus-and tumor-forming ability into nontumorigenic CHEF cells. Proc Natl Acad Sci USA (79): 1964–1968, 1982.

    Google Scholar 

  140. Cooper GM: Cellular transforming genes. Science (218): 801–806, 1982.

    Google Scholar 

  141. Robbins KC, Devare SG, Reddy EP, Aaronson SA, In vivo identification of the transforming gene product of Simian sarcoma virus. Science (218): 1131–1133, 1982.

    Google Scholar 

  142. Dalla-Favera R, Franchini G, Martinotti S, Wong-Stoal F, Gallo RC, Croce CM: Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes. Proc Natl Acad Sci USA (79): 4714–4717, 1982.

    Google Scholar 

  143. Dalla-Favera R, Gallo RC, Giallongo A, Croce CM: Chromosomal localization of the human homolog (c-sis) of the Simian sarcoma virus onc gene. Science (218): 686–688, 1982.

    Google Scholar 

  144. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM: Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA (79): 7824–7837, 1982.

    Google Scholar 

  145. heisterkamp N, Groffen J, Stephenson JR, Spurr NK, Goodfellow PN, Solomon E, Carritt B, Bodmer WF: Chromosomal localization of human cellular homologues of two viral oncogenes. Nature (299): 747–749, 1982.

    Google Scholar 

  146. Neel BG, Jhanwar SC, Chaganti RSK, Hayward WS: Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci USA (79): 7842–7846, 1982.

    Google Scholar 

  147. Rowley JD: Identification of the constant chromosome regions involved in human hematologic disease. Science (216): 749–751, 1982.

    Google Scholar 

  148. Lane MA, Sainten A, Cooper GM: Stage-specific transforming genes of human and mouse B- and T-lymphocyte neoplasms. Cell (28): 873–880, 1982.

    Google Scholar 

  149. Croce CM, Shander M, Martinis J, Cicurol L, D'Ancona GG, Dolby TW, Koprowski H: Chromosomal location of the genes for human immunoglobulin heavy chains. Proc Natl Acad Sci USA (76): 3416–3419, 1982.

    Google Scholar 

  150. Kirsch IR, Morton CC, Nakahara K, Leder P: Human immunoglobulin heavy chain genes map to a region of translocations in malignant B lymphocytes. Science (216): 301–303, 1982.

    Google Scholar 

  151. Lenoir GM, Preud'homme JL, Bernheim A, Berger R: Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. Nature (298): 474–476, 1982.

    Google Scholar 

  152. Biedler JL, Spengler BA: Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science (191): 185–187, 1976.

    Google Scholar 

  153. Balaban-Malenbaum G, Gilbert F: Double minute chromosomes and the homogeneously staining regions in chromosomes of a human neuroblastoma cell line. Science (198): 739–741, 1977.

    Google Scholar 

  154. Schimke RT (ed). Gene amplification. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982.

    Google Scholar 

  155. Gilbert F, Balaban G, Breg RW, Gallie B, Reid T, Nichols W: Homogeneously staining region in a retinoblastoma cell line: relevance to tumor initiation and progression. J Natl Cancer Inst (67): 301–306, 1981.

    Google Scholar 

  156. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF, Portlock C, Minna JD: Deletion 3p (14–23), double minute chromosomes, and homogeneously staining regions in human small-cell lung cancer. In: Schimke RT (ed). Gene amplification. cold Spring Harbor Laboratory, New York, 1982, pp 107–113.

    Google Scholar 

  157. Bertino JR, Srimatkandada S, Engel D, Medina WD, Scheer DI, Moroson BA, Dube S: Gene amplification in a methotrexate-resistant human leukemia line, K-562. In: Schimke RT (ed), Gene amplification. Cold Spring Harbor Laboratory, New York, 1982, pp 23–27.

    Google Scholar 

  158. Wolman SR, Craven ML, Grill SP, Domin BA, Cheng YC: Quantitative correlation of homogeneously stained regions on chromosome 10 with dihydrofolate reductase enzyme in human cells. Proc Natl Acad Sci USA (80): 807–809, 1983.

    Google Scholar 

  159. Dalla-Favera R, Wong-Staal F, Gallo RC: Onc gene amplification in promyelocytic leukemia cell line HL-60 and primary leukemia cells of the same patient. Nature (299): 61–63, 1982.

    Google Scholar 

  160. Mintz U, Vardiman J, Golomb HM, Rowley JD: Evolution of karyotypes in Philadelphia (Ph') chromosomenegative chronic myelogenous leukemia. Cancer (43): 411–416, 1979.

    Google Scholar 

  161. Testa JR, Mintz U, Rowley JE, Vardiman JW, Golomb HM: Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res (39): 3619–3627, 1979.

    Google Scholar 

  162. Balaban G, Herlyn M, Guerry D, Nowell P: Karyotype stability in the primary tumor and multiple metastases of a human melanoma. (Abstract). Proc Am Assoc Cancer Res (23): 34 1982.

    Google Scholar 

  163. Fialkow PH: Clonal origin of human tumors. Biochem Biophys Acta (458): 283–321, 1976.

    Google Scholar 

  164. Talmadge JE, Wolman SR, Fidler IJ: Evidence for the clonal origin of spontaneous metastases. Science (217): 361–363, 1982.

    Google Scholar 

  165. Spremulli EN, Dexter DL, Calabresi P: Clonal origin of spontaneous metastases in nude mice hosting a heterogeneous human tumor (in press).

  166. Radman M, Jeggo P, Wagner R: Chromosomal rearrangement and carcinogenesis. Mutat Res (98): 249–264, 1982.

    Google Scholar 

  167. Gilbert F: Genes, chromosomes, and cancer: an hypothesis J Natl Cancer Inst (in press).

  168. Clive D: Comparative chemical mutagenicity: can we make risk estimates: In: De Serres FJ, Shelly MD (eds), Comparative chemical mutagenesis. Plenum Press, New York, 1981, pp 1039–1066.

    Google Scholar 

  169. Cairns J: The origin of human cancers. Nature (289): 353–357, 1981.

    Google Scholar 

  170. Knudson AG JR: Genetic predisposition to cancer. In: Hiatt HH, Watson JD, Winsten JA (eds) Origins of human cancer. Cold Spring Harbor Laboratory, New York, 1978, pp 45–52.

    Google Scholar 

  171. D'Eustachio P, Ruddle FH: Somatic cell genetics and gene families Science (220): 919–923, 1983.

    Google Scholar 

  172. Kaneko et al. Cancer Res (41); 4577–4578, 1981.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, New York University, School of Medicine, New York, USA

    Sandra R. Wolman

Authors
  1. Sandra R. Wolman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolman, S.R. Karyotypic progression in human tumors. Cancer Metast Rev 2, 257–293 (1983). https://doi.org/10.1007/BF00048481

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00048481

Keywords

Search

Navigation